Biotech
SOUTH SAN FRANCISCO, CA: Proceeds to Support Clinical Development of GBT440 for the Treatment of Sickle Cell Disease ...
MANCHESTER, NH: Completed Sydney University Study Finds Glycemic Index Reduced Following Consumption of Sugary Beverages Along With sugardown(R) ...
LAVAL, QUEBEC: - IND for IVIG filed with the FDA - License/Milestone fees secured to contribute $ 9 million to Q4 2014 - Enrolment of DKD patients in PBI-4050 clinical program ongoing - no serious adverse events (&q ...
SOUTH SAN FRANCISCO, CA: SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 01/05/15 -- diaDexus, Inc. (OTCQB: DDXS), a company developing and commercializing proprietary cardiovascular diagnostic products, today highlighted recent ...
CORONA, CA: CORONA, CA -- (Marketwired) -- 01/05/15 -- SOHM, Inc. (OTC PINK: SHMN), a manufacturer of generic Pharmaceutical, Nutraceutical and Cosmeceutical drug products, announced today that it has received c ...
LOUISVILLE, CO: LOUISVILLE, CO -- (Marketwired) -- 01/05/15 -- ("Company") (OTCQB: ANTB), a biopharmaceutical corporation focused on developing novel extended release therapies, announced today that it ha ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/31/14 -- Abattis Bioceuticals Corp. (the "Company" or "Abattis") (OTCQX: ATTBF)(CSE: ATT), a specialty biotechnology company wi ...
MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 12/30/14 -- 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious diseases ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/29/14 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company"), announces that it received a notice, dated December 23, 2014 ...
BEVERLY, MA: BEVERLY, MA -- (Marketwired) -- 12/29/14 -- Cellceutix Corporation (OTCQB: CTIX) (the "Company"), a clinical stage biopharmaceutical company developing innovative therapies with oncology, d ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 12/29/14 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
DUBLIN, IRELAND: DUBLIN, IRELAND -- (Marketwired) -- 12/24/14 -- Horizon Pharma plc (NASDAQ: HZNP), a specialty biopharmaceutical company with a portfolio of products in arthritis, inflammation and orphan diseases, a ...
WINNIPEG, MANITOBA: WINNIPEG, MANITOBA -- (Marketwired) -- 12/23/14 -- Miraculins Inc. (TSX VENTURE: MOM) (the "Company"), a medical diagnostic company focused on acquiring, developing and commercializing dia ...
EXTON, PA: EXTON, PA -- (Marketwired) -- 12/22/14 -- In the news release issued Friday, December 19, 2014 by West Pharmaceutical Services, Inc. (NYSE: WST), we are advised by the company that the originally iss ...
LONDON, ONTARIO: Provides Further Support for Important COTI-2 Milestones; IND Filing and Clinical Trial Initiative ...
LAVAL, QUEBEC: LAVAL, QUEBEC -- (Marketwired) -- 12/22/14 -- ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF) -ProMetic Life Sciences Inc. (TSX: PLI)(OTCQX: PFSCF), ("ProMetic" or the "Corporati ...
SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 12/22/14 -- Linkage Biosciences, a leading manufacturer of tissue transplantation diagnostic products, announced a new long-term agreement to add manufacturing, ...
TORONTO, ON: TORONTO, ON -- (Marketwired) -- 12/22/14 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces it has suspended all types of financings considered more dilutionary compared to other financing opt ...
SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 12/22/14 -- Prima BioMed Ltd (NASDAQ: PBMD) (ASX: PRR) ("Prima", the "Company") is pleased to announce that it has received a Notice of Grant ...
BEVERLY, MA: Company Also Reports IRB Approval to Start Oral Mucositis Trial, Grant Awarded for HDP Mimics and Biotech Showcase on Tap ...
